Nordic Brain Tech AS
Nordic Brain Tech AS is a Norwegian digital therapeutics spin-off from NTNU that builds evidence-based biofeedback hardware, a migraine diary app, and a clinical trial dashboard to help patients and clinicians prevent and manage migraine, headache, and stress.
- Company typePrivate
- Founded2015
- HeadquartersOslo, Norway
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Nordic Brain Tech AS does
Nordic Brain Tech AS is a Norwegian digital therapeutics company, spun out of NTNU and St. Olavs Hospital research originating in 2015, that develops evidence-based biofeedback and digital health products for migraine, headache, and stress management. The portfolio comprises four products: Cerebri, a Class IIa medical device in CE-Mark certification under EU MDR that uses two wireless sensors (HRV/finger temperature and EMG/neck) paired with a smartphone app to deliver 10-minute daily biofeedback sessions over 12 weeks for migraine prevention; Cenli, a consumer wellness biofeedback device launched in Norway in September 2025 through wholly-owned subsidiary Cenli AS, combining HRV, finger temperature, and EMG sensors with a companion app for stress and nervous system regulation; Brain Twin, an iOS/Android headache diary app with symptom, medication, and menstrual tracking plus the premium Calmer breathing pacer, integrated with WebMed EHR in Norway and distributed in partnership with Pfizer Finland; and a Clinical Trial Dashboard for real-time, GDPR-compliant monitoring used in the BioCer and BioTenCer studies. The company earns revenue through one-time hardware sales (Cenli), a freemium app subscription (Brain Twin premium), and customized clinical trial dashboard solutions sold to research institutions, with the high-value Cerebri medical device pending CE-Mark and U.S. regulatory entry. Customers are primarily individual migraine and headache patients and stress-conscious consumers, with secondary B2B relationships including pharmaceutical channel partners, EHR vendors, and academic clinical trial sponsors across Norway, the United States, and Finland.
Nordic Brain Tech AS firmographics
Firmographics- Name
- Nordic Brain Tech AS
- Legal name
- Nordic Brain Tech AS
- Website
- https://nordicbraintech.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nordic Brain Tech AS is a Norwegian digital therapeutics spin-off from NTNU that builds evidence-based biofeedback hardware, a migraine diary app, and a clinical trial dashboard to help patients and clinicians prevent and manage migraine, headache, and stress.
- Ownership category
- akta.pro rank
Nordic Brain Tech AS industry classification
Industry- Product category
- Digital Therapeutics for Migraine and Headache Management
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Headache & Migraine Medicine (HLAKAIAE), Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL), Neurology Telemedicine Platforms (HLALAGAC), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Nordic Brain Tech AS is headquartered
LocationHeadquarters
- HQ city
- Oslo
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Nordic Brain Tech AS business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others
Revenue model
- Cenli Hardware Sales: Direct-to-consumer sales of Cenli biofeedback hardware device through own e-commerce platform cenli.no in Norway. First 1,000 units available at launch, with global market expansion planned for 2026.
- Brain Twin Premium Subscription: Freemium app model with premium subscription tier unlocking Calmer breathing pacer feature and additional functionality for migraine management.
- Cerebri Medical Device (Future): Planned Class IIa medical device for migraine prevention following CE marking under MDR, targeting European and US regulatory approval.
- Clinical Trial Dashboard: Customized web-based dashboard solutions for clinical trial monitoring sold to healthcare institutions, researchers, and pharmaceutical companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Cenli biofeedback device - one-time purchase |
| Freemium | Monthly | Brain Twin freemium with premium upgrade |
Go-to-market motion5 records
Distribution channels5 records
Marketing channels7 records
Nordic Brain Tech AS product offering
Product offeringCore offering
Nordic Brain Tech AS develops and commercializes digital therapeutics for migraine and headache management, originating from research at NTNU and St. Olavs Hospital. The company sells consumer biofeedback hardware (Cenli), a Class IIa medical device in development (Cerebri), a freemium headache-tracking mobile app (Brain Twin), and a web-based clinical trial monitoring dashboard. Products combine wireless physiological sensors with smartphone applications to enable home-based, drug-free, non-pharmacological treatment.
Product overview
Nordic Brain Tech offers a portfolio of digital health products focused on migraine and headache management. The core offerings include: (1) Cerebri - a Class IIa medical device under development for migraine prevention using home-based biofeedback therapy with wireless sensors; (2) Cenli - a consumer wellness biofeedback device for stress management currently available in Norway; (3) Brain Twin - an app-based headache diary for tracking migraines and headaches, available globally including USA and Finland; and (4) Clinical Trial Dashboard - a web-based platform for monitoring clinical trials. The products range from consumer wellness to medical device classification, with technology grounded in biofeedback research from NTNU and clinical validation.
Differentiator
Problem solved
Functional benefit
Brands
- Brain Twin: App-based digital headache diary for migraine diagnosis, tracking, and management, with features including headache logging, medication tracking, trend analysis, and a breathing pacer feature called Calmer.
- Cerebri
- Cenli
- Calmer
- Clinical Trial Dashboard
Products and services
- Cerebri Home-based biofeedback medical device for migraine prevention. Uses two wireless sensors (finger sensor for HRV/temperature, neck sensor for EMG) connected via Bluetooth to a smartphone app. Delivers 10-minute daily biofeedback sessions for 12 weeks. Class IIa medical device under MDR/ISO 13485 development, with CE-Mark process ongoing. Targets adults with episodic migraine seeking drug-free, non-pharmacological preventive treatment.
- Cenli Home-based consumer wellness biofeedback device for stress management. Combines HRV sensors, finger temperature sensors, and EMG sensors in one integrated system with companion smartphone app for nervous system training. Currently launched as a consumer wellness device in Norway through Cenli AS (wholly-owned subsidiary), with global expansion planned for 2026.
- Brain Twin App-based headache diary for diagnosis and management of migraines and headaches, available on iOS and Android. Features include headache tracking on pain intensity scale, medication logging, menstrual cycle data, trend visualization, dark mode for light sensitivity, and WCAG accessibility compliance. Freemium model with Calmer breathing pacer as premium feature. Integrated with WebMed EHR system in Norway. Used by tens of thousands of users worldwide.
- Clinical Trial Dashboard Web-based dashboard for real-time monitoring of clinical trials. Features include streamlined patient monitoring, tailored interface with customizable data fields, intuitive patient overview, and robust data security with GDPR compliance including advanced encryption, access controls, and regular audits. Used by clinical research teams in BioTenCer and BioCer studies.
Quantifiable outcome
- Reduces monthly migraine days by -0.9 days (95% CI -1.5 to -0.3, p = 0.002) compared to waitlist control over 12 weeks
- +4 more outcomes
Companies that use Nordic Brain Tech AS
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Nordic Brain Tech AS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature7 records
Nordic Brain Tech AS partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, major and minor.
- WebMedcoreBrain Twin integrated with WebMed electronic health record system, making it the first Norwegian headache app to operate on next-generation technology for app-EHR communication. WebMed is used by one in four Norwegian general practitioners, enabling seamless data sharing between patients and healthcare providers.
- Pfizer FinlandcoreNordic Brain Tech and Pfizer Finland launched Brain Twin as Finland's first Finnish-language migraine management application. The partnership enables Pfizer to offer cutting-edge digital migraine care technology to Finnish-speaking migraine sufferers, while Nordic Brain Tech gains distribution through a major pharmaceutical company's network.
- NTNU (Norwegian University of Science and Technology)coreCo-founders Anker Stubberud and Erling Tronvik are from NTNU and St. Olavs Hospital. Technology developed from NTNU research. Clinical trials conducted in collaboration with NTNU research institutions. NTNU technology transfer contributed to company formation.
- St. Olavs Hospital / University Hospital of TrondheimcoreClinical research partnership for BioCer and BioTenCer clinical trials. Senior Medical Advisors Erling Tronvik and Anker Stubberud are affiliated with St. Olavs Hospital. Principal Investigator Dr. Tore Wergeland Meisingset leads clinical trials at St. Olavs.
- Thorgate DigitalmajorThorgate is a key software development partner that helped develop and refine the software for Nordic Brain Tech's biofeedback device, contributing to the technical quality and reliability of the medical technology.
- TogethertechmajorTogether Tech developed the sensor technology and hardware for Cerebri and Cenli biofeedback devices over several years. Their expertise and commitment to quality were key to achieving performance and reliability standards in the sensors.
- NOME (Nordic Mentor Network for Entrepreneurship)minorThree-year mentoring program (extended from standard 2-year track) providing expert guidance from pharma, medtech, digital health, and commercialization mentors across Scandinavia. Included delegation trip to Mayo Clinic in Minneapolis for U.S. market exposure.
- DAM (Digital Accessibility Map)minorBrain Twin is listed as a partnership project with DAM (Digital Accessibility Map), supporting digital accessibility for users with disabilities.
- NorHEAD (Norwegian Centre for Headache Research)coreNorHEAD is the sponsor and coordinator of clinical trials including BioCer and BioTenCer, representing the Norwegian clinical research network for headache disorders.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Nordic Brain Tech AS competitors and assessment
Company assessmentEmerging players
- BehaVR: BehaVR develops prescription-grade VR-based digital therapeutics for chronic pain and mental health, with a similar clinical-evidence and regulatory-clearance playbook. It is a relevant emerging peer for Nordic Brain Tech as the company considers adjacent indications such as tension-type headache (BioTenCer) and chronic pain.
- Curelator (now part of Click Therapeutics assets / independent): Curelator developed a migraine tracking and prediction platform similar in concept to Brain Twin's ML-driven approach. Although now operating at smaller scale, it remains a meaningful peer for symptom-tracking and migraine prediction, the core software capability of Nordic Brain Tech.
Direct peers
- Akili Interactive: Akili Interactive pioneered FDA-cleared prescription digital therapeutics (EndeavorRx for ADHD, EndeavorOTC) and is exploring neurological and cognitive indications including migraine-relevant digital biomarkers. It is a direct peer given the regulated software-as-medical-device model targeting CNS conditions.
- Migraine Buddy (Healint): Healint's Migraine Buddy is one of the most-downloaded headache tracking apps globally with tens of millions of users. It is the most direct consumer-headache-app peer to Brain Twin and represents the incumbent that Nordic Brain Tech must differentiate against on data, clinical validation, and EHR integration.
- Voluntis (Aptar Digital Health): Voluntis, now part of Aptar Digital Health, develops connected therapeutics and digital companion apps for chronic conditions including oncology and diabetes, with pharma partnerships as a core GTM. It is comparable in revenue model (software + pharma channel) and disease-area focus to Nordic Brain Tech's Brain Twin.
- Click Therapeutics: Click Therapeutics is a prescription digital therapeutic company developing CT-132 for migraine prevention in partnership with Otsuka. It is a direct peer to Nordic Brain Tech's Cerebri given the same regulated DTx-for-migraine thesis, RCT-driven commercialization model, and pharma co-development approach.
- Mahana Therapeutics: Mahana Therapeutics is a prescription digital therapeutics company (Mahana IBS for irritable bowel syndrome) pursuing FDA clearance and payer reimbursement. It is a direct peer in the regulated DTx commercial model, scaling strategy, and digital-meets-clinical-meets-payer thesis relevant to Cerebri's future.
- Big Health: Big Health commercializes Sleepio (insomnia) and Daylight (anxiety), prescription digital therapeutics for CNS conditions with similar RCT-validation and payer-reimbursement strategies. The peer comparison is highly relevant for Nordic Brain Tech's pipeline expansion into anxiety/stress conditions beyond migraine.
- Pear Therapeutics (legacy/Boston Group): Pear Therapeutics pioneered the prescription digital therapeutic category (reSET, reSET-O, Pear-006) before its 2023 wind-down. It remains the closest historical peer for Nordic Brain Tech in terms of regulated DTx commercial model, payer engagement, and pipeline strategy, with assets now being shopped to acquirers.
Broad incumbents
- Headspace Health: Headspace Health is the largest mental wellness subscription app, with B2B enterprise distribution and an FDA-cleared digital therapeutic (Headspace Anxiety) for clinician prescription. It is a broad incumbent peer for Nordic Brain Tech's stress-management (Cenli) and anxiety-adjacent positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Nordic Brain Tech AS social profiles
Digital presenceNordic Brain Tech AS compliance and trust
Trust signalCompliance3 records
Nordic Brain Tech AS financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nordic Brain Tech AS leadership team
Management profileNumber of profiles
Profiles14 records
Nordic Brain Tech AS subsidiaries and ownership
Company hierarchySubsidiaries1 record
Nordic Brain Tech AS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nordic Brain Tech AS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nordic Brain Tech AS
What does Nordic Brain Tech AS do?
Nordic Brain Tech AS develops and commercializes digital therapeutics for migraine and headache management, originating from research at NTNU and St. Olavs Hospital. The company sells consumer biofeedback hardware (Cenli), a Class IIa medical device in development (Cerebri), a freemium headache-tracking mobile app (Brain Twin), and a web-based clinical trial monitoring dashboard. Products combine wireless physiological sensors with smartphone applications to enable home-based, drug-free, non-pharmacological treatment.
Is Nordic Brain Tech AS a public or private company?
Nordic Brain Tech AS is a private company. It is classified as venture growth investor backed and is currently operating.
When was Nordic Brain Tech AS founded?
Nordic Brain Tech AS was founded in 2015. It employs 11 to 50 people.
Where is Nordic Brain Tech AS based?
Nordic Brain Tech AS is headquartered in Oslo, Norway, in the Europe region.
How does Nordic Brain Tech AS make money?
Four revenue lines are on record. Cenli Hardware Sales are the primary driver. The others are brain Twin Premium Subscription, cerebri Medical Device (Future) and clinical Trial Dashboard.
Who are Nordic Brain Tech AS's main competitors?
Emerging players on record are BehaVR and Curelator (now part of Click Therapeutics assets / independent). Direct peers are Akili Interactive, Migraine Buddy (Healint), Voluntis (Aptar Digital Health), Click Therapeutics, Mahana Therapeutics, Big Health and Pear Therapeutics (legacy/Boston Group). Headspace Health is listed as a broad incumbent.
Does Nordic Brain Tech AS have an API?
No public API is recorded for Nordic Brain Tech AS.
What industry is Nordic Brain Tech AS in?
Nordic Brain Tech AS's product category is Digital Therapeutics for Migraine and Headache Management. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAE, Headache & Migraine Medicine. Its NAICS code is 334510 and its SIC code is 3845.